Pain Management

Patients who received the interventions reported improved anxiety and pain levels.

Dental opioid prescriptions are associated with risk of addiction and overdose, but most states are enacting policies that limit the duration of prescriptions for acute pain.

Sarah McDonald, cancer survivor and author of The Cancer Channel, discusses her experience battling 2 different unrelated cancers and the value oncology pharmacists could have provided with a greater presence on her care team.

Psilocybin is derived from certain types of mushrooms and has been proven to affect serotonin receptors.

The chronic and excessive use of opioids has been associated with a wide range of psychosocial effects on the patient.

There is a growing body of evidence that foods, substances, and additives in vitamins and supplements can be a trigger for migraine headaches.

Patient-controlled analgesia typically consists of opioids or local anesthetics, but it may also include non-opioid analgesics or other medications.

Results suggest pharmacists should use the phrase “bad reaction” to avoid stigma associated with the term “overdose.”

Program provides a virtual assessment and treatment with buprenorphine, a medication for opioid cravings and withdrawal symptoms.

Patient selection is a key factor in the safe and effective administration of advanced pain management modalities.

Leveraging pharmacogenomic testing, simultaneous multidrug analysis can help prevent drug interactions affecting pain management.

For patients with opioid use disorder, medication-assisted treatment programs are a clinically effective approach.

There is at least a 28% difference in the amount of licensed US substance use disorder facilities that accept Medicaid and private insurance compared to Medicare, according to new research.

Pharmacists can offer advice on nonpharmacologic and pharmacologic prevention and treatment strategies.

Updated prescribing guidelines issued in 2014 and 2016 may explain lower use of opioids by 11.7% among patients with chronic, nonsurgical pain.

Pharmacists and health care providers should be familiar with the management of xylazine overdose and withdrawal.

Although fentanyl is potent and often deadly, it is not passively absorbed into the bloodstream.

A session presenter at the ASCP 2022 Annual Meeting explained how patients’ mismanagement of medications for headaches can lead to rebound headaches.

Beth Macy, author of New York Times-bestselling book Dopesick and executive producer and writer on the Hulu series “Dopesick,” explains how FDA-approved drugs that treat opioid use disorder still aren’t getting into the hands of patients who need it most.

Researchers suggest that tapering a patient’s opioid medications and allowing them to maintain a health care plan can decrease the risk of developing opioid use disorder among other negative outcomes.

Eliminating paper prescriptions allows for greater legibility, security, trackability for pharmacists and providers.

Male students admitted into a high-performing public charter school found to have better physical health and lower body mass index than their female counterparts.

Dispensing naloxone provides an example of how small changes can make a significant difference.

With a simple intervention, pharmacists came off as compassionate and caring while their efficacy in treating patients improved.

Research suggests cannabis can improve quality of life for patients who suffer from pain and neurological disorders.

Online communities can help opioid users in remission maintain long-lasting sobriety, however the research suggests these communities should be non-drug-related.

Prescription drug monitoring programs have decreased prescription opioids in the United States but resulted in unintended spikes of illegal drug use and heroin-related deaths.

Doan’s magnesium salicylate tetrahydrate formulation treats pain from backaches.

Pharmacists can help by preventing and treating opioid use disorder and overdoses.

Zynrelef is indicated in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures.